Salem Investment Counselors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.4K | Sell |
398
-226
| -36% | -$19.8K | ﹤0.01% | 683 |
|
|
2026
Q1 | $56.5K | Buy |
+624
| New | +$57.3K | ﹤0.01% | 570 |
|
|
2025
Q4 | – | Sell |
-623
| Closed | -$61.6K | – | 1177 |
|
|
2025
Q3 | $61.6K | Sell |
623
-7
| -1% | -$694 | ﹤0.01% | 558 |
|
|
2025
Q2 | $57.6K | Buy |
630
+7
| +1% | +$677 | ﹤0.01% | 556 |
|
|
2025
Q1 | $70.7K | Hold |
623
| – | – | ﹤0.01% | 513 |
|
|
2024
Q4 | $66K | Sell |
623
-20
| -3% | -$2.15K | ﹤0.01% | 526 |
|
|
2024
Q3 | $69.6K | Hold |
643
| – | – | ﹤0.01% | 514 |
|
|
2024
Q2 | $69.9K | Hold |
643
| – | – | ﹤0.01% | 502 |
|
|
2024
Q1 | $85K | Buy |
643
+13
| +2% | +$1.62K | ﹤0.01% | 473 |
|
|
2023
Q4 | $76.8K | Sell |
630
-65
| -9% | -$7.25K | ﹤0.01% | 480 |
|
|
2023
Q3 | $78.1K | Sell |
695
-10
| -1% | -$1.27K | ﹤0.01% | 457 |
|
|
2023
Q2 | $103K | Hold |
705
| – | – | ﹤0.01% | 412 |
|
|
2023
Q1 | $91.2K | Buy |
705
+41
| +6% | +$5.15K | ﹤0.01% | 433 |
|
|
2022
Q4 | $84.9K | Hold |
664
| – | – | ﹤0.01% | 437 |
|
|
2022
Q3 | $70K | Buy |
664
+20
| +3% | +$2.19K | ﹤0.01% | 438 |
|
|
2022
Q2 | $68K | Buy |
644
+10
| +2% | +$1.19K | ﹤0.01% | 457 |
|
|
2022
Q1 | $81K | Sell |
634
-19
| -3% | -$2.29K | ﹤0.01% | 443 |
|
|
2021
Q4 | $81K | Hold |
653
| – | – | ﹤0.01% | 485 |
|
|
2021
Q3 | $93K | Sell |
653
-88
| -12% | -$12.9K | 0.01% | 422 |
|
|
2021
Q2 | $116K | Hold |
741
| – | – | 0.01% | 387 |
|
|
2021
Q1 | $115K | Hold |
741
| – | – | 0.01% | 353 |
|
|
2020
Q4 | $111K | Hold |
741
| – | – | 0.01% | 337 |
|
|
2020
Q3 | $98K | Buy |
741
+88
| +13% | +$11.5K | 0.01% | 307 |
|
|
2020
Q2 | $76K | Hold |
653
| – | – | 0.01% | 335 |
|
|
2020
Q1 | $64K | Buy |
653
+206
| +46% | +$27K | 0.01% | 319 |
|
|
2019
Q4 | $65K | Buy |
447
+1
| +0.2% | +$138 | 0.01% | 350 |
|
|
2019
Q3 | $60K | Hold |
446
| – | – | 0.01% | 350 |
|
|
2019
Q2 | $51K | Sell |
446
-103
| -19% | -$12.1K | ﹤0.01% | 370 |
|
|
2019
Q1 | $70K | Buy |
+549
| New | +$62.4K | 0.01% | 266 |
|
|
2018
Q4 | – | Sell |
-549
| Closed | -$70K | – | 396 |
|
|
2018
Q3 | $70K | Sell |
549
-45
| -8% | -$5.35K | 0.01% | 266 |
|
|
2018
Q2 | $64K | Hold |
594
| – | – | 0.01% | 268 |
|
|
2018
Q1 | $62K | Hold |
594
| – | – | 0.01% | 270 |
|
|
2017
Q4 | $70K | Hold |
594
| – | – | 0.01% | 279 |
|
|
2017
Q3 | $68K | Buy |
594
+92
| +18% | +$10.6K | 0.01% | 278 |
|
|
2017
Q2 | $63K | Sell |
502
-286
| -36% | -$33.9K | 0.01% | 291 |
|
|
2017
Q1 | $93K | Hold |
788
| – | – | 0.01% | 311 |
|
|
2016
Q4 | $79K | Buy |
+788
| New | +$84.5K | 0.01% | 316 |
|
Other funds holding ZBH
BTW
DLA
WAM
CS
MPMG
DJSG
ECSS
EIP
QAM
Salem Investment Counselors's ZBH Position: Q2 2026 in Review
Salem Investment Counselors reduced its Zimmer Biomet (ZBH) stake by 36% in Q2 2026, selling an estimated $19.8K and leaving 398 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #683.
Salem Investment Counselors first reported a position in ZBH in Q4 2016 and has held it in 37 quarters since. The position peaked at $116K in Q2 2021. 348 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Salem Investment Counselors held 398 shares of Zimmer Biomet worth $34.4K as of Q2 2026.
- Salem Investment Counselors sold 226 Zimmer Biomet shares in Q2 2026, an estimated $19.8K.
- Zimmer Biomet made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #683 holding.
- Salem Investment Counselors first reported a position in Zimmer Biomet in Q4 2016 and has held it in 37 quarters since.
- Salem Investment Counselors's Zimmer Biomet position peaked at $116K in Q2 2021.
- 348 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.